Comprehensive profile highlights microbiome and metabolomic changes as potential diabetes biomarkers, suggesting diagnostic advancements.
Our study provides a comprehensive profile of changes in the microbiome and serum metabolomics, indicating their potential application as biomarkers for future diagnosis and treatment in T2D.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: